Aarti Pharmalabs Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	2,724	2,169	1,935	1,223	-0.05
Depreciation & Amortization	816.44	719.65	625.43	421.19	-
Other Amortization	52.6	12.7	-	-	-
Loss (Gain) From Sale of Assets	-	-5.51	4.47	-0.4	-
Provision & Write-off of Bad Debts	12.81	10.68	15	-	-
Other Operating Activities	570.38	475.51	237.64	223.3	-
Change in Accounts Receivable	-844.33	-1,255	-351.72	-1,025	0.05
Change in Inventory	552.79	-396.64	-1,267	-559.92	-
Change in Accounts Payable	-569.13	433.48	1,302	-718.62	-
Operating Cash Flow	3,316	2,164	2,501	-437.04	-
Operating Cash Flow Growth	53.25%	-13.50%	-	-	-
Capital Expenditures	-4,020	-1,556	-1,021	-1,412	-
Sale (Purchase) of Intangibles	-418.41	-431.81	-175.29	-	-
Investment in Securities	228.34	-188.53	-391.23	-0.73	-
Other Investing Activities	71.47	30.74	9.77	24.86	-
Investing Cash Flow	-4,139	-2,146	-1,578	-1,387	-
Short-Term Debt Issued	278.61	499.94	-	2,723	-
Long-Term Debt Issued	1,000	-	-	-	-
Total Debt Issued	1,279	499.94	-	2,723	-
Short-Term Debt Repaid	-	-	-1,243	-	-
Long-Term Debt Repaid	-62	-49.3	-	-	-
Total Debt Repaid	-62	-49.3	-1,243	-	-
Net Debt Issued (Repaid)	1,217	450.64	-1,243	2,723	-
Issuance of Common Stock	0.04	-	-	-	-
Common Dividends Paid	-317.19	-181.25	-181.25	-	-
Other Financing Activities	-245.12	-172.15	-210.52	-119.59	-
Financing Cash Flow	654.35	97.24	-1,635	2,604	-
Miscellaneous Cash Flow Adjustments	-	0	-	-	-
Net Cash Flow	-169.01	115.14	-711.52	779.41	-
Free Cash Flow	-704.76	607.5	1,480	-1,849	-
Free Cash Flow Growth	-	-58.95%	-	-	-
Free Cash Flow Margin	-3.33%	3.28%	7.61%	-15.40%	-
Free Cash Flow Per Share	-7.77	6.70	16.33	-20.40	-
Cash Interest Paid	245.12	172.15	210.52	3.4	-
Cash Income Tax Paid	645.27	569.37	623.83	211.29	-
Levered Free Cash Flow	-2,176	-521.96	940.76	-6,998	-
Unlevered Free Cash Flow	-2,008	-414.37	1,072	-6,995	-
Change in Working Capital	-860.66	-1,219	-316.32	-2,304	0.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.